Novel non‐alcoholic steatohepatitis model with histopathological and insulin‐resistant features

Publisher： John Wiley & Sons Inc

E-ISSN： 1440-1827|68|1|12-22

ISSN： 1320-5463

Source： PATHOLOGY INTERNATIONAL, Vol.68, Iss.1, 2018-01, pp. : 12-22

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The independent predictors of non‐alcoholic steatohepatitis and its individual histological features.

By  

HEPATOLOGY RESEARCH, Vol. 46, Iss. 11, 2016-10 ,pp. : 1074-1087

John Wiley & Sons Inc

Access to resources Recommend Favorite

Abdominal subcutaneous adipose tissue insulin resistance and lipolysis in patients with non‐alcoholic steatohepatitis

By  

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 16, Iss. 7, 2014-07 ,pp. : 651-660

John Wiley & Sons Inc

Access to resources Recommend Favorite

Failure of islet β‐cell compensation for insulin resistance causes type 2 diabetes: What causes non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis?

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 25, Iss. 10, 2010-10 ,pp. : 1594-1597

John Wiley & Sons Inc

Access to resources Recommend Favorite

The pan‐caspase inhibitor Emricasan (IDN‐6556) decreases liver injury and fibrosis in a murine model of non‐alcoholic steatohepatitis

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 3, 2015-03 ,pp. : 953-966

John Wiley & Sons Inc

Access to resources Recommend Favorite

MicroRNA profiles following metformin treatment in a mouse model of non-alcoholic steatohepatitis

By                                          

International Journal of Molecular Medicine, Vol. 35, Iss. 4, 2015-01 ,pp. : 877-884

Spandidos Publications

Access to resources Recommend Favorite